| Literature DB >> 22367025 |
Luciana Scotti1, Marcus Tullius Scotti, Edeltrudes de Oliveira Lima, Marcelo Sobral da Silva, Maria do Carmo Alves de Lima, Ivan da Rocha Pitta, Ricardo Olímpio de Moura, Jaismary Gonzaga Batista de Oliveira, Rayssa Marques Duarte da Cruz, Francisco Jaime Bezerra Mendonça Junior.
Abstract
Fifty 2-[(arylidene)amino]-4,5-cycloalkyl[b]thiophene-3-carbonitrile derivatives were screened for their in vitro antifungal activities against Candida krusei and Cryptococcus neoformans. Based on experimentally determined minimum inhibitory concentration (MIC) values, we conducted computer-aided drug design studies [molecular modelling, chemometric tools (CPCA, PCA, PLS) and QSAR-3D] that enable the prediction of three-dimensional structural characteristics that influence the antifungal activities of these derivatives. These predictions provide direction with regard to the syntheses of new derivatives with improved biological activities, which can be used as therapeutic alternatives for the treatment of fungal infections.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22367025 PMCID: PMC6269054 DOI: 10.3390/molecules17032298
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1General structure of the studied 2-aminothiophenes.
Anti-Candida and anti-Criptococcus activities and chemical formulas of the studied 2-aminothiophene derivatives.
| Comp. | n | Ar | MIC (μg/mL) | |
|---|---|---|---|---|
| 1 | Ph | 2,500 | 1,250 | |
| 1 | 4-NO2-Ph | 1,250 | 2,500 | |
| 1 | 2-Thiophenyl | 156 | >10,000 | |
| 1 | 2-Indole | 1,250 | >10,000 | |
| 1 | 4-F-Ph | 2,500 | >10,000 | |
| 1 | 4-Br-Ph | 2,500 | >10,000 | |
| 1 | 4-Morpholine | 312 | >10,000 | |
| 1 | 4-OEt-Ph | 2,500 | >10,000 | |
| 1 | 4-Cl-Ph | 5,000 | 2,500 | |
| 1 | 4-OMe-Ph | 1,250 | 2,500 | |
| 1 | 2,3-Cl-Ph | 156 | >10,000 | |
| 1 | 3,4-Cl-Ph | >10,000 | 5,000 | |
| 1 | 2,4-Cl-Ph | 78 | 78 | |
| 1 | 3,4,5-OMe-Ph | 156 | 78 | |
| 1 | 2-OMe,5-Br-Ph | 156 | 78 | |
| 1 | 8-Quinoline | 156 | 5,000 | |
| 2 | 4-NO2-Ph | 1,250 | 128 | |
| 2 | 2-Indole | 78 | >10,000 | |
| 2 | 4-OBz-Ph | >10,000 | 625 | |
| 2 | 4-Br-Ph | >10,000 | >10,000 | |
| 2 | 4-Cl-Ph | >10,000 | >10,000 | |
| 2 | 4-OMe-Ph | 156 | 1,250 | |
| 2 | 4-F-Ph | 5,000 | 625 | |
| 2 | 2,3-Cl-Ph | 156 | 156 | |
| 2 | 3,4-Cl-Ph | 1,250 | 312 | |
| 2 | 2,4-Cl-Ph | 2,500 | >10,000 | |
| 2 | 3,4,5-OMe-Ph | 156 | 2,500 | |
| 2 | 2-OMe,5-Br-Ph | 10,000 | 10,000 | |
| 2 | 4-Pyrrolidine-Ph | 2,500 | 2,500 | |
| 2 | 3-Thiophenyl | 2,500 | >10,000 | |
| 2 | 3,4-OBz-Ph | 2,500 | 1,250 | |
| 2 | 8-Quinoline | 78 | 625 | |
| 2 | 4-Morpholine-Ph | 2,500 | 2,500 | |
| 3 | 4-Me-Ph | 156 | 2,500 | |
| 3 | 4-iPr-Ph | 1,250 | 2,500 | |
| 3 | Ph | >10,000 | 2,500 | |
| 3 | 4-NO2-Ph | 10,000 | 625 | |
| 3 | 2-indole | 312 | 2,500 | |
| 3 | 4-OBz-Ph | 10,000 | >10,000 | |
| 3 | 4-Br-Ph | 2,500 | 5,000 | |
| 3 | 4-Cl-Ph | 1,250 | 2,500 | |
| 3 | 4-OMe-Ph | 312 | 2,500 | |
| 3 | 4-OEt-Ph | 5,000 | 2,500 | |
| 3 | 3,4-Cl-Ph | 1,250 | 2,500 | |
| 3 | 2,4-Cl-Ph | >10,000 | 2,500 | |
| 3 | 3,4,5-OMe-Ph | 1,250 | 1,250 | |
| 3 | 2-OMe,5-Br-Ph | 10,000 | 5,000 | |
| 3 | 3-Thiophenyl | 2,500 | >10,000 | |
| 3 | 8-Quinoline | 78 | 625 | |
| 3 | 4-Et-Ph | 2,500 | 2,500 | |
Figure 2Ionisation potentials obtained for compounds 10, 22, 42, 2, 17 and 37.
Figure 3Maps of interaction with the probes H2O, N1 and O obtained for inactive compounds 20 and 45 and for active compounds 15 and 17.
Results of CPCA analyses of anti-Candida activities.
| PC | % explained variance from original data |
|---|---|
| 1 | 41.26 |
| 2 | 22.69 |
| 3 | 3.06 |
| 4 | 1.05 |
| 5 | 0.00 |
Results of CPCA analyses of anti-Cryptococcus activities.
| PC | % explained variance from original data |
|---|---|
| 1 | 45.03 |
| 2 | 20.11 |
| 3 | 4.00 |
| 4 | 0.98 |
| 5 | 0.00 |
Figure 4The relationship between the weights of the blocks of descriptors and the PC1 and PC2 components of the CPCA calculated using activities against C. krusei and C. neoformans.
Results of PCA analyses of anti-Candida activities.
| PC | % explained variance from original data |
|---|---|
| 1 | 43.77 |
| 2 | 20.58 |
| 3 | 2.33 |
| 4 | 1.71 |
| 5 | 0.09 |
Results of PCA analyses of anti-Cryptococcus activities.
| PC | % explained variance from original data |
|---|---|
| 1 | 39.80 |
| 2 | 22.75 |
| 3 | 3.56 |
| 4 | 1.00 |
| 5 | 0.08 |
Figure 5Positions of objects in relation to PC1 and PC2 components. Blue represents more active compounds, lilac represents compounds that are moderately active, and pink represents less active compounds.
Figure 6Graph of experimental versus calculated activity values, predicted by Equation (1).
pIC50 values, residues and standard deviation (SD) of the mean of the residues of the tested series.
| pIC50 calculated | pIC50 observed | Residues | SD |
|---|---|---|---|
| 2.54 | 2.38 | 0.16 | 0.26 |
| 3.87 | 3.70 | 0.17 | |
| 3.72 | 3.67 | 0.05 | |
| 2.28 | 1.53 | 0.75 | |
| 2.27 | 2.09 | 0.18 |
Statistical parameters of PLS model.
| LV | SDEC | SDEP | R2 | Q2 |
|---|---|---|---|---|
| 5 | 0.18 | 0.48 | 0.91 | 0.77 |
Figure 7Best fit model obtained in PLS.